Comparable expression of matrix metalloproteinases 1 and 2 in pouchitis and ulcerative colitis

Gut

Volumn 47, Issue 3, 2000, Pages 415-422

  Stallmach, A ^a   Chan, C C ^a,b   Ecker, K W ^a   Feifel, G ^a   Herbst, H ^c   Schuppan, D ^d   Zeitz, M ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b CATHAY GENERAL HOSPITAL   (Taiwan)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Ileo anal pouch; Matrix metalloproteinases; Pouchitis

Indexed keywords

COLLAGENASE; GELATINASE A; METRONIDAZOLE;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; ILEITIS; ILEOANAL ANASTOMOSIS; IMMUNOBLOTTING; IN SITU HYBRIDIZATION; NORTHERN BLOTTING; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADENOMATOUS POLYPOSIS COLI; ADOLESCENT; ADULT; BLOTTING, NORTHERN; BLOTTING, WESTERN; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IN SITU HYBRIDIZATION; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MESODERM; MIDDLE AGED; POUCHITIS;

EID: 0033863450     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.47.3.415     Document Type: Article

References (39)

1. 1 Parks AG, Nicholls RJ. Proctocolectomy without ileostomy. BMJ 1978;2:85-8.
2. 2 Taylor BA, Dozois RR. The J ileal pouch-anal anastomosis. Wold J Surg 1987;11:727-34.
3. 3 Sandborn WJ. Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology 1994;107:1856-60.
4. 4 Raghow R. The role of extracellular matrix in postinflammatory wound healing and fibrosis. FASEB J 1994;8:823-31.
5. 5 Airola K, Vaalamo M, Reunala T, Saarialho KU. Enhanced expression of interstitial collagenase, stromelysin-1, and urokinase plasminogen activator in lesions of dermatitis herpetiformis. J Invest Dermatol 1995;105:184-9.
6. 6 Clark IM, Powell LK, Ramsey S, Hazleman BL, Cawston TE. The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 1993;36:372-9.
7. 7 Conway JG, Wakefield JA, Brown RH, et al. Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor. J Exp Med 1995;182:449-57.
8. 8 Gunja SZ, Morales AR, Romanelli R, Woessner JJ. Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy. Role of metalloproteinases and pyridinoline cross-links. Am J Pathol 1996;148:1639-48.
9. 9 Grant G, Gimbernardi T, Grant A, Klebe R. Overview of expression of matrix metalloproteinases (MMP-17, MMP-18, and MMP-20) in cultured human cells. Matrix Biol 1999;18:145-8.
10. 10 Matrisian L. The matrix-degrading metalloproteinases. Bioessays 1992;14:455-63.
11. 11 Woessner JFJ. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991;5: 2145-54.
12. 12 Kerkvliet EH, Docherty AJ, Beertsen W, Everts V. Collagen breakdown in soft connective tissue explants is associated with the level of gelatinase A (MMMP-2) but not with collagenase. Matrix Biol 1999;18:373-80.
13. 13 Sympson CJ, Talhouk RS, Alexander CM, et al. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J Cell Biol 1994;125: 681-93.
14. 14 Pender SL, Tickle SP, Docherty AJP, Howie D, Wathen NC, MacDonald TT. A major role for matrix metalloproteinases in T cell injury in the gut. J Immunol 1997;158:1582-90.
15. 15 Bailey CJ, Hembry RM, Alexander A, Irving MH, Grant ME, Shuttleworth CA. Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine. J Clin Pathol 1994;47:113-16.
16. 16 Matthes H, Matthes B, Stallmach A, Schuppan D, Herbst H, Riecken EO. mRNA expression of collagenase type I and TV is increased in ulcerative colitis compared to Crohn's disease and controls. Gastroenterology 1992;102: A661.
17. 17 Günther U, Matthes H, Herbst H, Stallmach A, Riecken EO, Schuppan D. Phenotype of cells expressing matrix metalloproteinases-3 in ulcerative colitis. Ann N Y Acad Sci 1998;859:304-6.
18. 18 Baugh MD, Perry MJ, Hollander AP, et al. Matrix metalloproteinase levels are elevated in inflammatory bowel disease. Gastroenterology 1999;117:814-22.
19. 19 Saarialho-Kere U, Vaalamo M, Puolakkainen P, Airola K, Parks W, Karjalainen-Lindsberg M. Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastro-intestinal ulcers. Am J Pathol 1996;148:519-26.
20. 20 Vaalamo M, Karjalainen-Lindsberg ML, Puolakkainen P, Kere J, Saarialho-Kere U. Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations. Am J Pathol 1998;152:1005-14.
21. 21 Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual. New York: Cold Spring Harbor Laboratory Press, 1982.
22. 22 Matthes H, Herbst H, Schuppan D, et al. Cellular localization of procollagen gene transcripts in inflammatory bowel diseases. Gastroenterology 1992;102:431-42.
23. 23 Orzechowski H-D, Beckenbach C, Herbst H, Stölzel U, Riecken EO, Stallmach A. Expression of CD44v6 is associated with cellular dysplasia in colorectal epithelial cells. Eur J Cancer 1995;31A:2073-9.
24. 24 Günther U, Schuppan D, Bauer M, et al. Fibrogenesis and fibrolysis in collagenous colitis: Patterns of procollagen types I and IV, matrix-metalloproteinase-1 and -13, and TIMP-1-gene expression. Am J Pathol 1999;155:493-503.
25. 25 von Lampe B, Barthel B, Kroesen AJ, Buhr HJ, Riecken EO, Rosewicz S. Zentrale Role der Matrix-Metalloproteinase-I und ihres Inhibitors bei der mukosalen Adaptation im ileoanalen Pouch sowie bei der Pouchitis. Z Gastroenterol 1999;37:857A.
26. 26 Pender SLF, Breese EJ, Günther U, et al. Suppression of T cell-mediated injury in human gut by interleukin 10: role of matrix metalloproteinases. Gastroenterology 1998;115:573-83.
27. 27 Milani S, Herbst H, Schuppan D, et al. Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver. Am J Pathol 1994;144:528-37.
28. 28 Stallmach A, Schäfer F, Weber S, et al. Increased state of activation of CD4-positive T cells and elevated interferon-γ production in pouchitis. Gut 1998;43:499-505.
29. 29 Patel RT, Bain I, Youngs D, Keighley MRS. Cytokine production in pouchitis is similar to that in ulcerative colitis. Dis Colon Rectum 1995;38:831-7.
30. 30 Graham MF, Willey A, Adams J, Yager D, Diegelmann RF. Interleukin 1 beta down-regulates collagen and augments collagenase expression in human intestinal smooth muscle cells. Gastroenterology 1996;110:344-50.
31. 31 Unemori EN, Bair MJ, Bauer EA, Amento EP. Stromelysin expression regulates collagenase activation in human fibroblasts. Dissociable control of two metalloproteinases by interferon-gamma. J Biol Chem 1991;266:23477-82.
32. 32 Krane SM. Some molecular mechanisms of glucocorticoid action. Br J Rheumatol 1993;32(suppl 2):3-5.
33. 33 Graham MF, Willey A, Zhu YN, Sugerman H. Critical interaction of c-jun and glucocorticoid receptor in the regulation of collagenase-1 expression by human intestinal smooth muscle cells. Gastroenterology 1999;116:A726.
34. 34 Brenner DA, O'Hara M, Angel P, Chojkier M, Karin M. Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha. Nature 1989;337:661-3.
35. 35 Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999;340:1398-405.
36. 36 Brennan FM, Browne KA, Green PA, Jaspar JM, Maini RN, Feldmann M. Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy. Br J Rheumatol 1997;36:643-50.
37. 37 Pender SL, Fell JM, Chamow SM, Ashkenazi A, MacDonald TT. A p55 TNF receptor immunoadhesin prevents T cell-mediated intestinal injury by inhibiting matrix metalloproteinase production. J Immunol 1998;160:4098-103.
38. 38 Shepherd NA, Jass JR, Duval I, Moskowitz RL, Nicholls RJ, Morson BC. Restorative proctocolectomy with ileal reservoir: pathological and histochemical study of mucosal biopsy specimens. J Clin Pathol 1987;40:601-7.
39. 39 Daum S, Bauer U, Foss HD, et al. Expression of mRNA for matrix metalloproteinases 1 and 3, tissue inhibitor of metalloproteinases-1 and collagen-1 in intestinal biopsies of patients with coeliac disease. Gut 1999;44:17-24.